Focal laser coagulation in the treatment of a patient with kidney cancer and prostate cancer
Teodorovich, O.V.; Shatokhin, M.N.; Naryshkin, S.A.; Abdullayev, M.I.; Krasnov, A.V.; Borisenko, G.G.; Zhurbenko, A.A.
Urologiia 2: 55-58
2019
ISSN/ISBN: 1728-2985 PMID: 31162902 Document Number: 699573
The article describes the clinical observation of the patient 84 years old with prostate cancer T2bNxM0, left kidney cancer T1N0M0 and severe comorbidity. Stepwise interstitial laser coagulation was performed using the Russian microsecond Nd: YAG laser surgical complex.
Document emailed within 1 workday
Related Documents
Gorbatiy, V.; Castle, S.M.; Ramanathan, R.; Leveillee, R.J. 2010: Imaging and focal therapy in prostate and kidney cancer Panminerva Medica 52(4): 297-306Dann, T.; Schüller, J.; Schmeller, N.T.; Arnholdt, H.; Hofstetter, A.G. 1989: Treatment of distal urethral cancer by laser coagulation Der Urologe. Ausg. a 28(5): 296-299
Fourcade, R-Olivier.; Richaud, P.; Coloby, P.; Malavaud, B. 2007: Role of 150 mg bicalutamide in the treatment of prostate cancer: 3rd analysis of the EPC (early prostate cancer) program Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 17(4 Suppl. 1): 891-910
Muschter, R.; Zellner, M.; Hessel, S.; Hofstetter, A. 1994: Interstitial laser coagulation of the prostate: experiences in the treatment of benign prostatic hyperplasia Progress in Clinical and Biological Research 386: 521-527
Moul, J.W.; Saad, F. 2005: Low-risk prostate cancer patient: active treatment Canadian Journal of Urology 12(Suppl 2): 25-27
Claros, O.R.; Tourinho-Barbosa, R.R.; Carneiro, A.; Collura-Merlier, S.; Macek, P.; Lanz, C.; Cathala, N.; Prapotnich, D.; Mombet, A.; Sanchez-Salas, R.; Cathelineau, X. 2019: HIFU focal therapy for prostate cancer using intraoperatory contrast enhanced ultrasound Archivos Espanoles de Urologia 72(8): 825-830
Crawford, E.David.; Barqawi, A. 2007: Targeted focal therapy: a minimally invasive ablation technique for early prostate cancer Oncology 21(1): 27-32; Discussion: 33-4 39
Conard, J.; James, J.M.; Dautzenberg, B.; Berault-Audoin, J.; Samama, M.; Diebold, J.; Bilski-Pasquier, G.; Bousser, J. 1976: Disseminated intravascular coagulation during cancer of the prostate with diffuse hematogenic dissemination La Nouvelle Presse Medicale 5(42): 2867-2868
Williams, J.C. 1996: Interstitial laser coagulation of the prostate Techniques in Urology 2(3): 130-135
Huang, W.Tsung.; Chang, K.Chao.; Shan, Y.Shen.; Tsao, C.Jung.; Lee, J.Chang. 2005: Successful initial treatment with weekly 24-hour infusion of 5-fluorouracil and leucovorin in a rectal cancer patient with acute disseminated intravascular coagulation Hepato-Gastroenterology 52(65): 1436-1439
Kochegarov, A.A.; Grigor'iants, A.A.; Kochegarova, G.I. 1990: Endoscopic laser coagulation of the tumor in patients with cancer of the esophagus and proximal portion of the stomach Voprosy Onkologii 36(5): 587-591
Sun, S.-C.; Zhao, H.; Liu, R.; Wang, B.-L.; Liu, Y.-Q.; Zhao, Y.; Shi, Z.-D. 2017: Expression of long non-coding RNA H19 in prostate cancer and its effect on the proliferation and glycometabolism of human prostate cancer cells Zhonghua Nan Ke Xue 23(2): 120-124
Considine, B.; Petrylak, D.P. 2019: Integrating Novel Targets and Precision Medicine into Prostate Cancer Care-Part 1: the Non-Androgen-Targetable Pathways in Castration-Resistant Prostate Cancer Oncology 33(3): 113-118
Grosclaude, P.; Menegoz, F.; Schaffer, P.; Macé Lesec'h, J.; Arveux, P.; Le Mab, G.; Soulié, M.; Villers, A. 1997: Prostate cancer screening (II): is prostate cancer a public health problem? Update of incidence and mortality figures in France from 1982 to 1990 Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 7(4): 647-654
Pinto, F.; Brescia, A.; Sacco, E.; Volpe, A.; Gardi, M.; Gulino, G.; Bassi, P. 2009: Disseminated intravascular coagulation secondary to metastatic prostate cancer: case report and review of the literature Archivio Italiano di Urologia Andrologia: Organo Ufficiale di Societa Italiana di Ecografia Urologica e Nefrologica 81(4): 212-214
Liu, J-he.; Li, H-wei.; Tong, M.; Li, M.; Na, Y-qun. 2004: Genetic risk factors of prostate cancer in Han nationality population in Northern China and a preliminary study of the reason of racial difference in prevalence of prostate cancer Zhonghua Yi Xue Za Zhi 84(5): 364-368
Ragde, H.; Grado, G.L.; Nadir, B.S. 2001: Brachytherapy for clinically localized prostate cancer: thirteen-year disease-free survival of 769 consecutive prostate cancer patients treated with permanent implants alone Archivos Espanoles de Urologia 54(7): 739-747
Perrin, P.; François, O.; Maquet, J.H.; Bringeon, G.; Duteil, P.; Devonec, M. 1991: Circulating prostate cancer specific antigens in benign hypertrophy and localized cancer of the prostate Presse Medicale 20(28): 1313-1319
Zissimopoulos, A.; Stellos, K.; Matthaios, D.; Petrakis, G.; Parmenopoulou, V.; Babatsikou, F.; Matthaiou, E.; Theodosiadou, E.; Hountis, P.; Koutis, C. 2009: Type i collagen biomarkers in the diagnosis of bone metastases in breast cancer, lung cancer, urinary bladder cancer and prostate cancer. Comparison to CEA, CA 15-3, PSA and bone scintigraphy Journal of Buon: Official Journal of the Balkan Union of Oncology 14(3): 463-472
Pan, Y.-z.; Xiao, X.-y.; Zhao, D.; Zhang, L.; Ji, G.-y.; Li, Y.; He, D.-c.; Zhao, X.-j.; Yang, B.-x. 2005: Proteomic analysis of prostate cancer using surface enhanced laser desorption/ionization mass spectrometry Zhonghua Yi Xue Za Zhi 85(45): 3172-3175